Point72 Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Point72 Asset Management's PFE Position: Q2 2026 in Review
Point72 Asset Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 4,365,063 shares — an estimated $114M sold.
Point72 Asset Management first reported a position in PFE in Q3 2014 and held it in 12 quarters. The position peaked at $123M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Point72 Asset Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Point72 Asset Management sold 4,365,063 Pfizer shares in Q2 2026, an estimated $114M.
- Point72 Asset Management first reported a position in Pfizer in Q3 2014 and held it in 12 quarters.
- Point72 Asset Management's Pfizer position peaked at $123M in Q1 2026.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.